Company: NDRA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001654954-25-003612
Chunk: 124

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1
Chunk 124
---
 between the Company and Michael Thornton* 8-K10.205/12/1710.11First Amendment to Employment Agreement, dated December 27, 2019, by and between the Company and Michael Thornton* 8-K10.212/27/1910.12Services Agreement, dated March 25, 2024, between the Company and Impact Solve, LLC*x   10.13Employment Agreement, dated August 13, 2024, by and between the Company and Alexander Tokman* 10-Q10.111/19/2410.14Gross Lease, dated January 1, 2015, between the Company and Green Court LLC S-110.1811/21/1610.15Amendment to Gross Lease, dated October 10, 2017, by and between the Company and Green Court LLC 10-Q10.205/15/1810.16Second Amendment to Lease, dated March 15, 2021, by and between the Company and Green Court LLC 10-K10.1803/25/2110.17Third Amendment to Lease, dated December 1, 2024, by and between the Company and Green Court LLCx   10.18Consulting Agreement, dated October 17, 2023, by and between the Company and Alexander Tokman* 10-K10.2103/28/2410.19Offer Letter, dated June 9, 2021, by and between the Company and Irina Pestrikova* 10-K10.2203/28/2419.1ENDRA Life Sciences Inc. Insider Trading Policyx   21.1Subsidiaries of the Company 10-K21.103/30/2223.1Consent of RBSM LLP, Independent Registered Public Accounting Firm (with respect to Forms S-3)x   23.2Consent of RBSM LLP, Independent Registered Public Accounting Firm (with respect to Forms S-8)x   24.1Power of Attorney (included on signature page)x   31.1Certification Pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934x   31.2Certification Pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934x   32.1Certification Pursuant